Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
IQVIA Holdings Community
NYSE:IQV Community
3
Narratives
written by author
0
Comments
on narratives written by author
20
Fair Values set
on narratives written by author
Create a narrative
IQVIA Holdings
Popular
Undervalued
Overvalued
Community Investing Ideas
IQVIA Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 21 Analysts
Collaboration With NVIDIA Will Advance AI Healthcare Solutions
Key Takeaways Leveraging AI in clinical trials and partnerships with pharma firms enhances margins and revenue growth potential. Projects with NVIDIA and R&D demand create favorable growth conditions, enhancing product offerings and long-term earnings.
View narrative
US$221.31
FV
32.1% undervalued
intrinsic discount
4.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
IQV
IQV
IQVIA Holdings
Your Fair Value
US$
Current Price
US$150.28
60.2% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
20b
2015
2018
2021
2024
2025
2027
2030
Revenue US$19.7b
Earnings US$1.8b
Advanced
Set Fair Value